171 results on '"Christine Canning"'
Search Results
2. Suppl. Figs from Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
3. Supplemental Table 1 legend from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
4. Suppl. Figs Legends from Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
5. Suppl. Tables from Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
6. Data from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
7. Data from Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
8. Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
9. Outside influences: as they keep a close eye on new home construction and housing resale statistics, reducing overall costs and answering performance and regulatory demands remain top priorities for manufacturers of exterior coatings
10. Bringing color to life: some customers are very comfortable with color, others not so much. Hard work behind the scenes brings color alive for everyone
11. Fourth annual R&D salary survey: our annual look at what's on the minds and in the wallets of R&D staffers in the global coatings industry
12. The powder coatings market: with 'easy' conversions and double-digit growth gone from the U.S. and Western Europe, powder coatings manufacturers are eyeing Asia for growth. But will spiraling raw materials prices and the inability to promote the value of their products hamper their efforts to remain profitable?
13. Send in the crowds: the European Coatings Show remains the paint and coatings industry's top event. This year, the show drew 19,000 attendees to Nurnberg, while 800 took part in six adjoining technical conferences
14. Color trends & forecasting: although changes are more evolutionary than revolutionary in the architectural paint market, trends and hot colors move through more quickly now than ever before. Paint companies spend a considerable amount of time and money to create color collections and marketing materials to entice even the most conservative customers
15. Automotive coatings market: Asia continues to lure--and reward--carmakers and their paint suppliers
16. Architectural and decorative coatings market: companies are optimistic about the prospects for 2005. But how will rising raw material and packaging component prices affect their business?
17. Expo report: ICE 2004: FSCT held its International Coatings Expo (ICE) Oct. 27-29 in Chicago. Did the show meet expectations on both side of the aisles?
18. Third annual R&D salary survey: our annual look at what R&D staffers earn and what's on their minds as they formulate today's coatings and raw materials
19. Rad-cure raw materials and equipment: suppliers continue to develop new offerings to improve and expand the use of UV and EB formulations
20. The evolution of low- and zero-VOC paint: the latest generation of low- and zero-VOC architectural paint offers better performance, feel and finish attributes. Can manufacturers take it to the next level and make these products more mainstream?
21. Radcure coatings: UV and EB coatings technology continues to impact many industries, delivering environmental and performance benefits to a variety of companies ranging from multi-billion dollar cosmetic giants to high-end cabinet makers to the local auto repair shop
22. Automotive coatings market: with production numbers down in North America and Western Europe, automakers are finding it harder to maintain profit levels and are seeking growth in emerging markets. Coating companies need to deliver better products and help OEMs reduce overall costs
23. The architectural and decorative coatings market: coming off a solid 2003, architectural coatings manufacturers are optimistic about 2004 and have a range of new products and programs aimed at enticing customers and winning market share
24. NPCA meets in Florida: Orlando, FL played host to the National Paint and Coatings Association's 116th annual meeting
25. R&D salary survey: our second annual look at how much paint R&D staffers earn and what's really on their minds as they spend countless hours in the lab
26. Marine and Yacht coatings: performance and speed matter most to boat and ship owners and even the recreational user. The same can be said about the coatings that protect their investment
27. Rad-cure raw materials & equipment update: suppliers to this market are feeling the pains of the current sagging economy, but are looking ahead to growth that will come from new markets
28. Aerospace coatings: it's tough times for commercial airlines, airplane manufacturers and their suppliers. The good news: aircraft in operation today need to be repainted at some point, and there's always Asia
29. Industrial, OEM & coil coatings: readying for recovery; when manufacturing slows, so does the need for coatings. But by taking a closer look at their own operations, paint companies are readying themselves for the market's recovery. (Cover Story)
30. Review: ICE 2002: the major windfall from ICE 2002 centered around the decision to switch the show's format to an every-other-year schedule
31. Automotive refinish market: paint plays a vital role in restoring a classic to its former glory or repairing the family SUV after an accident. But the repair industry faces major challenges ranging from increased competition to pricing pressures to new technology. Paint suppliers need to do more than just sell products
32. Adhesives & sealants market update: between the economy and increased competition, cost pressures and environmental hurdles, adhesives and sealant manufacturers look to acquisitions to boost their business
33. Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
34. Abstract P2-15-03: A Phase Ib Study of an adjuvant GM-CSF-Secreting Breast Cancer Vaccine
35. Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
36. Balancing act: battling corrosion is a never-ending quest in which paint formulators need to supply their customers with solutions that balance performance with health, safety and environmental issues
37. Pretty tough: focused R&D has helped suppliers create new special-effect and high-performance pigments
38. Automotive refinish market: with profitability the ultimate goal--for themselves and their customers--paint suppliers look to emerging markets and new technologies
39. Form and function: formulators can create paint that performs and pleases when incorporating high performance and special effect pigments
40. RadTech's e/5 UV & EB Expo: Charlotte show posts record participation by conference-goers and expo attendance figures reminiscent of 2000 event
41. Resins update: paint companies are running leaner, and resins suppliers are shouldering more responsibility at a time when their own production costs are escalating
42. Mixing equipment update: in slower economic times, equipment purchases often get put on the back burner. But it's wise to keep a watchful eye on current machinery. Is there ever a good time for unscheduled maintenance and production slowdowns?
43. Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
44. A 'next generation' supplier: with a complete range of metallic and pearlescent pigment technologies and its Louisville facility up and running at top speed, Eckart has carved out a niche as a leading supplier of special effect pigment technologies to NAFTA, Europe and the rest of the world
45. Metallic pigments: new finishes on the rise: silver remains the most popular color in the auto market. But designers are on the prowl for new finishes with metallic flair
46. Getting it right: tinting, coloring and dispensing: when all aspects come together, customers go home happy
47. Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
48. Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens
49. Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation
50. Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.